Cargando…
MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway
BACKGROUND: Mesenchymal stem cells (MSCs) are favourable treatments for ischaemic diseases; however, MSCs from diabetic patients are not useful for this purpose. Recent studies have shown that the expression of miR-34a is significantly increased in patients with hyperglycaemia; the precise role of m...
Autores principales: | Zhang, Fengyun, Gao, Fei, Wang, Kun, Liu, Xiaohong, Zhang, Zhuoqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866658/ https://www.ncbi.nlm.nih.gov/pubmed/33546760 http://dx.doi.org/10.1186/s13287-021-02183-2 |
Ejemplares similares
-
Retraction Note to: MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway
por: Zhang, Fengyun, et al.
Publicado: (2021) -
Protective effect of hydrogen sulfide on endothelial cells through Sirt1-FoxO1-mediated autophagy
por: Zhu, Lin, et al.
Publicado: (2020) -
FoxO3 increases miR-34a to cause palmitate-induced cholangiocyte lipoapoptosis
por: Natarajan, Sathish Kumar, et al.
Publicado: (2017) -
miR-181a increases FoxO1 acetylation and promotes granulosa cell apoptosis via SIRT1 downregulation
por: Zhang, Mei, et al.
Publicado: (2017) -
Resveratrol Pretreatment Improved Heart Recovery Ability of Hyperglycemic Bone Marrow Stem Cells Transplantation in Diabetic Myocardial Infarction by Down-Regulating MicroRNA-34a
por: Zhang, Fengyun, et al.
Publicado: (2021)